One of the fundamental challenges of microdosing is that most people are working with unregulated substances. There's no pharmaceutical quality control, no standardized dosing, and no consumer protection. Understanding what you're working with—and the limits of what you can know—is essential for safe practice.
The Quality Problem
Pharmaceutical medications go through rigorous manufacturing processes. Every pill contains a precise, verified amount of active ingredient. Every batch is tested for purity. Microdosing substances have none of these guarantees.
Mushrooms vary naturally in potency. Two mushrooms from the same growing flush can differ significantly in psilocybin content. Caps typically contain more psilocybin than stems. Growing conditions, genetics, harvest timing, and drying methods all affect potency. Even within a single dried batch, individual pieces can vary.
LSD presents different challenges. Since it's synthesized, potency should theoretically be more consistent within a batch—but you're relying on whoever made it to have accurate dosing. Street LSD is notoriously unreliable in terms of actual dosage. What's sold as "100 micrograms" could be 50 or 200. Additionally, what's on the blotter might not be LSD at all—research chemicals with similar effects but different safety profiles are sometimes substituted.
Contamination Risks
Beyond potency, contamination is a real concern:
Misidentification. If you're obtaining mushrooms from informal sources, there's a risk that what you receive isn't what you think it is. Some toxic mushroom species can resemble psilocybin-containing ones.
Mold and bacteria. Improperly dried or stored mushrooms can harbor mold or bacterial growth. This is particularly concerning for people with compromised immune systems.
Adulterants. LSD can be adulterated with other psychoactive substances, some of which have different safety profiles, duration, and dose-response curves.
Legal Options
In some jurisdictions, legal or semi-legal options exist. For a comprehensive overview, see our article on the legal landscape. Some notable examples:
The Netherlands allows the sale of psilocybin-containing truffles through licensed "smart shops." These are a different form of the same fungi that produce mushrooms, and they're sold with some degree of standardization.
Jamaica has no laws prohibiting psilocybin, and retreat centers operate openly.
Amanita muscaria (fly agaric) is legal in many places because its active compounds (muscimol and ibotenic acid) are different from psilocybin. However, it produces distinctly different effects and has its own safety considerations.
Cannabis, where legal, is sometimes microdosed, though this is a different practice from psychedelic microdosing.
Harm Reduction for Sourcing
If you're obtaining substances outside legal channels:
Know your source. Relationships matter. A trusted source with a consistent supply is safer than anonymous transactions. Community referrals carry more weight than online claims.
Test what you get. For LSD, Ehrlich reagent testing is straightforward and affordable. A positive Ehrlich reaction confirms the presence of an indole compound (which LSD is), though it can't confirm purity or dosage. It can, however, rule out some common substitutes.
For mushrooms, visual identification is the primary tool, but it requires knowledge. If you're not confident in identification, don't guess.
Start low. With any new batch—even from a trusted source—start with a dose lower than what you've used before. Potency variation is the most common reason for unexpectedly strong effects.
Grind and homogenize. For mushrooms, grinding your entire supply into powder and mixing thoroughly averages out the potency variation between individual pieces. This doesn't guarantee perfect consistency, but it significantly narrows the range. Our storage and preparation guide covers this process step by step.
The Uncomfortable Truth
Working with unregulated substances means accepting a degree of uncertainty that wouldn't exist with pharmaceutical products. You can minimize risk through testing, careful sourcing, and conservative dosing—but you can't eliminate it.
This is one of the strongest arguments for legal regulation and pharmaceutical standardization of microdosing substances. Until that exists, harm reduction practices are the best available approach.